Regulatory flexibility for COVID-19 research --- https://t.co/UXwGA14NwL
RT @GovindPersad: On improvement of accessibility to trials, I found this paper interesting https://t.co/erirgzWbS1 & also https://t.co/se4…
On improvement of accessibility to trials, I found this paper interesting https://t.co/erirgzWbS1 & also https://t.co/se4c2VTFOZ by @HollyLynchez @pzettler @SteveJoffe @emily_a_largent
RT @OSULawDEPC: A new article from DEPC and @OSU_Law Associate Professor @pzettler and collaborators was recently published in the Journal…
RT @OSULawDEPC: A new article from DEPC and @OSU_Law Associate Professor @pzettler and collaborators was recently published in the Journal…
A new article from DEPC and @OSU_Law Associate Professor @pzettler and collaborators was recently published in the Journal of Law and the Biosciences. Read "Regulatory Flexibility for #COVID19 Research" at https://t.co/8tihrjEWiA https://t.co/NBULHDmkK6
RT @HollyLynchez: Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19…
RT @HollyLynchez: Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19…
RT @pzettler: Delighted to publish in the special pandemic issue of @J_Law_Biosci. Check out @HollyLynchez, @EmoryMedicine's Neal Dickert,…
RT @pzettler: Delighted to publish in the special pandemic issue of @J_Law_Biosci. Check out @HollyLynchez, @EmoryMedicine's Neal Dickert,…
RT @PennMEHP: "Our proposals for regulatory flexibility in these areas seek to satisfy the goals of protecting participants and promoting t…
RT @HollyLynchez: Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19…
RT @PennMEHP: "Our proposals for regulatory flexibility in these areas seek to satisfy the goals of protecting participants and promoting t…
RT @HollyLynchez: Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19…
RT @HollyLynchez: Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19…
RT @HollyLynchez: Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19…
RT @HollyLynchez: Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19…
RT @HollyLynchez: Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19…
RT @HollyLynchez: Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19…
Didn't have the chance to tweet this out yesterday! Very pleased to have our paper, "Regulatory Flexibility for COVID-19 Research," published by the Journal of Law and the Biosciences. Great collaboration with @SteveJoffe @pzettler @emily_a_largent + Neal
RT @PennMEHP: "Our proposals for regulatory flexibility in these areas seek to satisfy the goals of protecting participants and promoting t…
"Our proposals for regulatory flexibility in these areas seek to satisfy the goals of protecting participants and promoting the development of high-quality evidence to improve patient care." https://t.co/VmpFFskBX5 @HollyLynchez @SteveJoffe @emily_a_largen
RT @pzettler: Delighted to publish in the special pandemic issue of @J_Law_Biosci. Check out @HollyLynchez, @EmoryMedicine's Neal Dickert,…
RT @pzettler: Delighted to publish in the special pandemic issue of @J_Law_Biosci. Check out @HollyLynchez, @EmoryMedicine's Neal Dickert,…
RT @SteveJoffe: Really pleased to see this article on regulatory flexibility for research oversight out with @HollyLynchez, Neal Dickert, @…
RT @SteveJoffe: Really pleased to see this article on regulatory flexibility for research oversight out with @HollyLynchez, Neal Dickert, @…
RT @pzettler: Delighted to publish in the special pandemic issue of @J_Law_Biosci. Check out @HollyLynchez, @EmoryMedicine's Neal Dickert,…
RT @pzettler: 👇👇 https://t.co/yuon6bS05c
RT @SteveJoffe: Really pleased to see this article on regulatory flexibility for research oversight out with @HollyLynchez, Neal Dickert, @…
RT @pzettler: Delighted to publish in the special pandemic issue of @J_Law_Biosci. Check out @HollyLynchez, @EmoryMedicine's Neal Dickert,…
RT @rosario_isasi: Regulatory Flexibility for COVID-19 Research | Journal of Law and the Biosciences | Oxford Academic https://t.co/zzN18H2…
RT @pzettler: Delighted to publish in the special pandemic issue of @J_Law_Biosci. Check out @HollyLynchez, @EmoryMedicine's Neal Dickert,…
Delighted to publish in the special pandemic issue of @J_Law_Biosci. Check out @HollyLynchez, @EmoryMedicine's Neal Dickert, me, @SteveJoffe & @emily_a_largent on regulatory flexibility for Covid-19 research (w potential lessons for other research as
RT @SteveJoffe: Really pleased to see this article on regulatory flexibility for research oversight out with @HollyLynchez, Neal Dickert, @…
Regulatory Flexibility for COVID-19 Research | Journal of Law and the Biosciences | Oxford Academic https://t.co/zzN18H21HV
RT @HankGreelyLSJU: /2 Francesca Bellazzi, Konrad v Boyneburgk, COVID-19 calls for virtue ethics, https://t.co/0Fp8BX4SFN Holly Fernandez…
👇👇
/2 Francesca Bellazzi, Konrad v Boyneburgk, COVID-19 calls for virtue ethics, https://t.co/0Fp8BX4SFN Holly Fernandez Lynch, Neal W Dickert, Patricia J Zettler, Steven Joffe, Emily A Largent, Regulatory Flexibility for COVID-19 Research, https://t.co/amD